Journal Information
Vol. 39. Issue 12.
Pages 580-600 (December 2003)
Share
Share
Download PDF
More article options
Vol. 39. Issue 12.
Pages 580-600 (December 2003)
Full text access
Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas
Visits
...
A. Xaubeta,
Corresponding author
axaubet@clinic.ub.es

Correspondencia: Servei de Pneumologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España
, J. Ancocheab, R. Blanquerc, C. Monterod, F. Morelle, E. Rodríguez Becerraf, A. Sueirog, V. Villenah, Grupo de Investigación en Enfermedades Pulmonares Intersticiales Difusas. Área de Técnicas y Trasplante. Separ
a Servicio de Neumología. Hospital Clínic. Barcelona. España
b Servicio de Neumología. Hospital de La Princesa. Madrid. España
c Servicio de Neumología. Hospital Dr. Peset. Valencia. España
d Servicio de Neumología. Hospital Juan Canalejo. A Coruña. España
e Servicio de Neumología. Hospital Vall d'Hebron. Barcelona. España
f Servicio de Neumología. Hospital Virgen del Rocío. Sevilla. España
g Servicio de Neumología. Hospital Ramón y Cajal. Madrid. España
h Servicio de Neumología. Hospital 12 de Octubre. Madrid. España
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D. Olivieri, R.M. Du Bois.
Interstitial lung diseases.
European Respiratory Monograph, 5 (2000),
[2.]
M. Selman.
Neumopatías intersticiales difusas,
[3.]
American Thoracic Society/European Respiratory Society.
Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement.
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[4.]
American Thoracic Society/European Respiratory Society.
International multidisciplinary consensus classification of the idiopathic interstitial pneumonias.
Am J Respir Crit Care Med, 165 (2002), pp. 277-304
[5.]
M. Demetds, A.U. Wells, J.M. Antó, U. Costabel, R. Hubbard, P. Cullinan, et al.
Interstitial lung diseases: an epidemiological overview.
Eur Respir J, 18 (2001), pp. 2S-16S
[6.]
M.I. Schwarz.
Clinical overview of interstitial lung disease.
Interstitial lung disease, pp. 2-30
[7.]
M. Cushley, A. Davison, R.M. Du Bois, C. Flower, A. Greening, N. Ibrahim, et al.
BTS Guidelines. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults.
Thorax, 54 (1999), pp. 1-30
[8.]
F. Morell, G. Levy, R. Orriols, J. Ferrer, J. De Gracia, G. Sampol.
Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis.
Chest, 121 (2002), pp. 1239-1244
[9.]
A. Chetta, M. Aiello, A. Foresi, E. Marango, R. D'Ippolito, A. Castagnaro, et al.
Relatioship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease.
Sarcoidosis Vasc Diffuse Lung Dis, 18 (2001), pp. 170-175
[10.]
ATS statement.
Guidelines for the six-minute walk test.
Am J Respir Crit Care Med, 166 (2002), pp. 111-117
[11.]
J. Castella, J. Ancochea, L. Llorente, C. Puzo, J. Sanchis, A. Sueiro, et al.
Normativa SEPAR: lavado broncoalveolar.
Arch Bronconeumol, 33 (1997), pp. 515-526
[12.]
R.J. Panos, R.L. Mortenson, S.A. Niccoli, T. King.
Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.
Am J Med, 88 (1990), pp. 396-404
[13.]
T. Fumeaux, C. Rothmeier, P. Jolliet.
Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis.
Intens Care Med, 27 (2001), pp. 1868-1874
[14.]
H.A. Ghofrani, R. Wiedemann, F. Rose, R.T. Schermuly, H. Olschewski, N. Weissmann, et al.
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
[15.]
International guidelines for selection of lung transplant candidates.
Am J Respir Crit Care, 158 (1998), pp. 335-340
[16.]
E.P. Trulock.
Lung transplantation: state of the art.
Am J Resp Crit Care, 155 (1998), pp. 789-818
[17.]
J. De Meester, J.M. Smits, G. Persijn, A. Haverich.
Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the eurotransplant experience.
J Heart Lung Transplant, 20 (2001), pp. 518-524
[18.]
N. Mogulkoc, M. Brutsche, P. Bishop, S.M. Greaves, A.W. Horrocks, J.J. Egan.
Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.
Am J Resp Crit Care, 164 (2001), pp. 103-108
[19.]
J. Hosenpud, L. Bennett, B. Keck, E.B. Edwards, R.J. Novick.
Effect of diagnosis on survival benefit of lung transplantation for endstage lung disease.
[20.]
B.A. Johnson, S.R. Duncan, N.P. Ohori, I.L. Paradis, S.A. Yousem, W.F. Grgurich, et al.
Recurrence of sarcoidosis in pulmonary allograft recipients.
Am Rev Resp Dis, 148 (1993), pp. 1373-1377
[21.]
J. De Vries, B.L.J. Kessels, M. Drent.
Quality of life of idiopathic pulmonary fibrosis.
Eur Respir J, 17 (2001), pp. 954-961
[22.]
A. Xaubet, C. Agustí, P. Luburich, J. Roca, C. Monton, M.C. Ayuso, et al.
Pulmonary function tests and CT scans in the management of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 158 (1998), pp. 431-446
[23.]
A.L. Katzenstein, J.L. Myers.
Idiopathic pulmonary fibrosis. Clinical relevance and pathologic classification.
Am J Respir Crit Care Med, 157 (1998), pp. 1301-1315
[24.]
M. Selman, T.E. King, A. Pardo.
Idiopathic pulmonary fibrosis: prevailing and evolving hypothese about its pathogenesis and implications for therapy.
Ann Intern Med, 134 (2001), pp. 136-151
[25.]
T.J. Gross, G.W. Hunninghake.
Idiopathic pulmonary fibrosis.
N Engl J Med, 345 (2001), pp. 517-525
[26.]
T.E. King, J.A. Tooze, M.I. Schwarz, K.R. Brown, R.M. Cherniack.
Predicting survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 164 (2001), pp. 1171-1181
[27.]
A. Xaubet, C. Agustí, P. Luburich, J. Roca, M.C. Ayuso, R.M. Marrades, et al.
Is it necessary to treat all patients with idiopathic pulmonary fibrosis?.
Sarcoidosis Vasc Diffuse Lung Dis, 18 (2001), pp. 289-295
[28.]
R. Ziesche, E. Hofbauer, K. Wittmann, V. Petrov, L.H. Block.
A preliminary study of long term treatment with interferon gamma 1-b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
N Engl J Med, 341 (1999), pp. 1264-1269
[29.]
K.R. Flaherty, G.B. Toews, W.D. Travis, T.V. Colby, E.A. Kazerooni, B.H. Gross, et al.
Clinical significance of histological classifica-tion of idiopathic interstitial pneumonia.
Eur Respir J, 19 (2002), pp. 275-283
[30.]
R. Lazor, A. Vandevenne, A. Pelletier, P. Lecrec, I. Court-Fortune, J.F. Cordier.
Cryptogenic organizing pneumonia.
Am J Respir Crit Care Med, 162 (2000), pp. 571-577
[31.]
D. Bouros, A.C. Nicholson, V. Polychronopoulos, R.M. Du Bois.
acute interstitial pneumonia.
Eur Respir J, 15 (2000), pp. 412-418
[32.]
R. Ichikado, M. Suga, N.L. Müller, H. Taniguchi, Y. Kondoh, M. Akira, et al.
acute interstitial pneumonia. Comparison of high-resolution computed tomography findings between survivors and nonsurvivors.
Am J Respir Crit Care Med, 165 (2002), pp. 1551-1556
[33.]
V. Jason, K.K. Brown, C.D. Cool, D.A. Young, R.M. Cherniak, T.E. King, et al.
acute interstitial pneumonitis: case series and review of the literature.
Medicine (Baltimore), 79 (2000), pp. 369-378
[34.]
U. Costabel.
Sarcoidosis: clinical update.
Eur Respir J, 18 (2001), pp. 56S-68S
[35.]
L.S. Newman, C.S. Rose, L.A. Maier.
Sarcoidosis.
N Engl J Med, 336 (1994), pp. 1224-1234
[36.]
J. Mañá, F. Badrinas, J. Morera, E. Fite, F. Manresa, F. Fernández-nogués.
Sarcoidosis in Spain.
Sarcoidosis, 9 (1992), pp. 118-122
[37.]
G.W. Hunninghake, U. Costabel, M. Ando, R. Baughman, J.F. Cordier, R. Du Bois, et al.
Statement on sarcoidosis.
Am J Respir Crit Care Med, 160 (1999), pp. 736-755
[38.]
R.P. Baughman, A.S. Teirstein, M.A. Judson, M.D. Rossman, J.r. Yeager H, E.A. Bresnitz.
A Case Control Etiologic Study of Sarcoidosis (ACCES) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis.
Am J Respir Crit Care Med, 164 (2001), pp. 1885-1889
[39.]
G.J. Gibson, R.J. Prescott, M.F. Muers, W.G. Middleton, D.N. Mitchell, C.K. Connolly, et al.
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.
Thorax, 51 (1996), pp. 238-247
[40.]
S. Paramothayan, P.W. Jones.
Corticosteroid therapy in pulmonary sarcoidosis. A systematic review.
Jama, 287 (2002), pp. 1301-1307
[41.]
M.A. Judson.
An approach to the treatment of pulmonary sarcoidosis with corticosteroids. The six phases of treatment.
Chest, 115 (1999), pp. 1158-1165
[42.]
R.P. Baughman, E.E. Lower.
Alternatives to corticosteroids in the treatment of sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis, 14 (1997), pp. 121-130
[43.]
R.P. Baughman, E.E. Lower.
A clinical approach to the use of methotrexate for sarcoidosis.
Thorax, 54 (1999), pp. 742-746
[44.]
J. Müller, K. Kienast, M. Held, S. Pfeifer, U. Costabel.
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen.
Eur Respir J, 14 (1999), pp. 1117-1122
[45.]
G.J. Gibson.
Sarcoidosis: old and new treatments.
Thorax, 56 (2001), pp. 336-339
[46.]
A.G. Nicholson, T.V. Colby, A.U. Wells.
Histopathological approach to patterns of interstitial pneumonia in patients with connective tissue disorders.
Sarcoidosis Vasc Diffuse Lung Dis, 19 (2002), pp. 10-17
[47.]
C. Lamblin, C. Bergoin, T. Saelens, B. Wallaert.
Interstitial lung diseases in collagen vascular diseases.
Eur Respir J, 18 (2001), pp. 69S-80S
[48.]
G.S. Cheema, F.P. Quismorio.
Interstitial lung disease in systemic lupus erythematosus.
Curr Opin Pulm Med, 6 (2000), pp. 424-429
[49.]
W.W. Douglas, H.D. Tazelaar, T.E. Hartman, R.P. Hartman, P.A. Decker, D.R. Schroeder, et al.
Polymyositis-dermatomyositis-associated interstitial lung disease.
Am J Respir Crit Care Med, 164 (2001), pp. 1182-1185
[50.]
D. Deheinzelin, V.L. Capelozzi, R.A. Kairalla, J.V.B. Filho, P.H.N. Saldiva, C.R.R. De Carvalho.
Interstitial lung disease in primary Sjögren's syndrome: clinical-pathological evaluation and response to treatment.
Am J Respir Crit Care Med, 154 (1996), pp. 794-799
[51.]
W.A. Schmidt, W. Wetzel, R. Friedländer, R. Lange, H.F. Sorensen, H.J. Lichey.
Clinical and serological aspects of patients with anti Jo-1 antibodies: an evolving spectrum of disease manifestations.
Clin Rheumatol, 19 (2000), pp. 371-377
[52.]
D. Bouros, A.U. Wells, A.G. Nicholson, T.V. Colby, V. Polychronopoulos, P. Pantelidis.
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relation to outcome.
Am J Respir Crit Care Med, 165 (2002), pp. 1581-1586
[53.]
S. Miyake, Y. Ohtano, M. Sawada, N. Inase, V. Miyazaki, S. Takano, et al.
Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Sarcoidosis Vasc Diffuse Lung Dis, 19 (2002), pp. 128-133
[54.]
B. White, W.C. Moore, F.M. Wigley, H.O. Xiao, R.A. Wise.
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
Ann Intern Med, 132 (2000), pp. 947-954
[55.]
A.M. Patel, J.H. Ryu, C.E. Reed.
Hypersensitivity pneumonitis: current concepts and future questions.
J Allergy Clin Immunol, 108 (2001), pp. 661-670
[56.]
S.J. Bourke, J.C. Dalphin, G. Boyd, C. McSharry, C.I. Baldwin, J.E. Calvert.
Hypersensitivity pneumonitis: current concepts.
Eur Respir J, 18 (2001), pp. 81S-92S
[57.]
M. Hinojosa, J. Frag, B. De la Hoz, A. Sueiro.
Hypersensitivity pneumonitis in workers exposed to asparto grass (stipa tenacissima fibers).
J Allergy Clin Immunol, 95 (1996), pp. 985-991
[58.]
F. Morell, V. Curull, R. Orriols, J. De Gracia.
Skin tests in bird breeder's disease.
Thorax, 41 (1986), pp. 538-541
[59.]
A. Ramírez-Venegas, R.H. Sansores, R. Pérez-padilla, G. Carrillo, M. Selman.
Utility of a provocation test for diagnosis of chronic pigeon breeder's disease.
Am J Respir Crit Care Med, 158 (1998), pp. 862-869
[60.]
M. Schuyler, Y. Cormier.
The diagnosis of hypersensitivity pneumonitis.
Chest, 111 (1997), pp. 534-536
[61.]
S.H. Abid, V. Malhotra, M.C. Perry.
Radiation-induced and chemotherapy- induced pulmonary injury.
Curr Opin Oncol, 13 (2001), pp. 242-248
[62.]
P.H. Camus, P. Foucher, P.H. Bonniaud, K. Ask.
Drug-induced infiltrative lung disease.
Eur Respir J, 18 (2001), pp. 93S-100S
[63.]
E. Hancock, J. Osborne.
Lymphangioleiomyomatosis: a review of the literature.
Respir Med, 96 (2002), pp. 1-6
[64.]
A. Roman, D. Aristizábal, E. Pallisa, J. Majó, M. Iscar, V. Monforte, et al.
Linfangioleiomiomatosis: estudio de 15 pacientes.
Med Clin (Barc), 115 (2000), pp. 98-102
[65.]
J. Kelly, J. Moss.
Lymphangioleiomyomatosis.
Am J Med Sci, 321 (2001), pp. 17-25
[66.]
S.R. Johnson, A.E. Tattersfield.
Clinical experience of lymphangioleiomyomatosis in the UK.
Thorax, 55 (2000), pp. 1052-1057
[67.]
K. Matsui, A. Tatsuguchi, J. Valencia, Z. Yu, J. Bechtle, M.B. Beasley, et al.
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.
Hum Pathol, 31 (2000), pp. 1242-1248
[68.]
J. Moss, N.A. Ávila, P.M. Barnés, R.A. Litzenberger, J. Bechtle, P.G. Brooks, et al.
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Am J Respir Crit Care Med, 164 (2001), pp. 669-671
[69.]
W.T. Miller.
Pulmonary Langerhans'-cell histiocytosis.
N Engl J Med, 343 (2000), pp. 1656-1660
[70.]
D.M. Howarth, G.S. Gilchrist, B.P. Mullan, G.A. Wiseman, J.H. Edmonson, P.J. Schomberg.
Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.
Cancer, 85 (1999), pp. 2278-2290
[71.]
F. Morell, L. Reyes, J. Majó, R. Orriols, A. Román.
Histiocitosis de células de Langerhans. Estudio clínico y evolución a largo plazo de 21 pacientes.
Med Clin (Barc), 115 (2000), pp. 60-64
[72.]
P. Weinmann, B. Crestani, A. Tazi, T. Genereau, H. Mal, M. Aubier, et al.
111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
J Nucl Med, 41 (2000), pp. 1808-1812
[73.]
R. Vassallo, J.H. Ryu, D.R. Schroeder, P.A. Decker, A.H. Limper.
Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.
N Engl J Med, 346 (2002), pp. 484-490
[74.]
J.F. Seymour, J.J. Presneill.
Pulmonary alveolar proteinosis.
Am J Respir Crit Care Med, 166 (2002), pp. 215-235
[75.]
M.S. Chesnutt, T.J. Nuckton, J. Golden, H.G. Folkesson, M.A. Matthay.
Rapid alveolar epithelial fluid clearance following lung lavage in pulmonary alveolar proteinosis.
Chest, 120 (2001), pp. 271-274
[76.]
R. Ben-Abraham, A. Greenfeld, J. Rozenman, I. Ben-Dov.
Pulmonary alveolar proteinosis: step-by-step perioperative care of whole lung lavage procedure.
Heart Lung, 31 (2002), pp. 43-49
[77.]
J.F. Seymour, J.J. Presneill, O.D. Schoch, G.H. Downie, P.E. Moore, I.R. Doule, et al.
Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.
Am J Respir Crit Care Med, 163 (2001), pp. 524-531
[78.]
E.D. Chan, D.V. Morales, C.H. Welsh, M.T. McDermott, M.L. Schwarz.
Calcium deposition with or without bone formation in the lung.
Am J Respir Crit Care Med, 165 (2002), pp. 1654-1669
[79.]
A. Senyigit, A. Yaramis, F. Gurkan, G. Kirbas, H. Buyukbayram, H. Nazaroglu, et al.
Pulmonary alveolar microlithiasis: a rare familial inheritance with report of six cases in a family. Contribution of six new cases to the number of case reports in Turkey.
Respiration, 68 (2001), pp. 204-209
[80.]
H. Hoshino, H. Koba, S. Inomata, K. Kurokawa, Y. Morita, K. Yoshida, et al.
Pulmonary alveolar microlithiasis: high-resolution CT and MR findings.
J Comput Assist Tomogr, 22 (1998), pp. 245-248
[81.]
J.F. Cordier.
Eosinophilic pneumonias.
Interstitial lung disease, 3rd ed, pp. 559-596
[82.]
J. Ancochea.
Eosinofilias pulmonares.
Medicina interna, 14.a ed, pp. 950-954
[83.]
M. Rosenberg, R. Patterson, R. Mintzer, B.J. Cooper, M. Roberts, K.E. Harris.
Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis.
Ann Intern Med, 86 (1977), pp. 405-414
[84.]
F. Philit, B. Etienne-Mastroianni, A. Parrot, C. Guerin, D. Robert, J.F. Cordier.
Idiopathic acute eosinophilic pneumonia: a study of 22 patients.
Am J Respir Crit Care Med, 166 (2002), pp. 12135-12139
[85.]
A. Churg, F.H.Y. Green.
Pathology of occupational lung disease,
[86.]
W.R. Parkes.
Occupational lung disorders,
[87.]
D.J. Hendrick, P.S. Burge, W.S. Beckett, A. Churg.
Occupational disorders of the lung,
[88.]
P.H. Camus, T.V. Colby.
The lung in inflammatory bowel disease.
Eur Respir J, 15 (2000), pp. 5-10
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología

Subscribe to our newsletter

Article options
Tools

Are you a health professional able to prescribe or dispense drugs?